Table 3

Procedures and hospital treatment in patients with acute myocardial infarction by age group and symptom presentation

<65years n=54 488≥65years n=114 493
Without chest pain
n=4157
With chest pain n=54 331Without chest pain n=17 834With chest pain n=96 659
Angiography, n (%)2279 (54.8)34 670 (63.8)4815 (27.0)42 844 (44.3)
Thrombolysis, n (%)275 (6.6)11 042 (20.3)633 (3.6)16 767 (17.4)
Cardiac intervention (CABG/PCI), n (%)1404 (33.8)29 481 (54.3)2836 (15.9)33 979 (35.2)
CPR, n (%)297 (7.1)1478 (2.7)1152 (6.5)4110 (4.3)
Inotropic agents, n (%)329 (7.9)1259 (2.3)1284 (7.2)4042 (4.2)
LMWH, n (%)2892 (69.6)37 097 (68.3)10 941 (61.4)61 679 (63.8)
Aspirin/antiplatelets, n (%)3520 (84.7)51 080 (94)13 492 (75.7)83 515 (86.4)
β-blocker*, n (%)3525 (84.8)49 865 (91.8)13 389 (75.1)82 165 (85)
ACE inhibitor/ARB, % (n)2610 (62.8)28 580 (52.6)10 061 (56.4)53 293 (55.1)
Statins, n (%)2922 (70.3)43 151 (79.4)8659 (48.6)59 108 (61.2)
Calcium blocker, n (%)510 (12.3)5271 (9.7)2296 (12.9)14 419 (14.9)
Diuretics*, n (%)2127 (51.2)11 334 (20.9)12 843 (72)47 589 (49.2)
  • *Oral and/or intravenously.

  • AMI, acute myocardial infarction; ARB, angiotensin receptor blocker; CABG, coronary artery bypass grafting; CPR, cardiopulmonary resuscitation; LMWH, low molecular weight heparin; PCI, percutaneous coronary intervention.